Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-11-03
1990-04-24
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546176, 546153, 546155, 546156, 546171, 546172, 546174, 546175, 546177, 546178, 546179, 546180, C07D21512, C07D21514, C07D40302, A61K 3147
Patent
active
049201301
ABSTRACT:
This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.
REFERENCES:
patent: 4282230 (1981-08-01), Hoehn
patent: 4661499 (1987-04-01), Young et al.
patent: 4769461 (1988-09-01), Musser et al.
Campbell Henry F.
Galemmo, Jr. Robert A.
Huang Fu-chi
Balogh Imre (Jim)
Nicholson James A.
Rorer Pharamceutical Corp.
Savitzky Martin
Springer David B.
LandOfFree
Quinoline derivatives and use thereof as antagonists of leukotri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives and use thereof as antagonists of leukotri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives and use thereof as antagonists of leukotri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-34961